CA
CalciMedica, Inc. (CALC)
NASDAQ·Healthcare·Biotechnology
$1.43
+5.15%
Mkt Cap $9.29M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$266.00
Range $14.00 – $392.00
Implied Upside
+18501.4%
Consensus $266.00 vs current $1.43
NASDAQ·Healthcare·Biotechnology
$1.43
+5.15%
Mkt Cap $9.29M
No recent rating data.
Price Target (3 analysts)
$266.00
Range $14.00 – $392.00
+18501.4%
Consensus $266.00 vs current $1.43